MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Is levodopa-induced dyskinesia in Parkinson’s disease associated with increased blood brain barrier permeability and volumetric changes?

    O. Segal, D. Last, D. Guez, Y. Mardor, G. Yahalom, O.S. Cohen, S. Benizri, C. Hoffman, S. Hassin-Baer (Ramat Gan, Israel)

    Objective: The aim of this study was to explore the angiogenetic hypothesis for Levodopa-induced-dyskinesia (LID) using advanced MRI methods in patients with Parkinson's disease (PD).…
  • 2016 International Congress

    Parkinson’s disease onset on non-dominant side predicts greater motor disability

    T.A. Finseth, S. Sillau, B. Berman (Aurora, CO, USA)

    Objective: Evaluate (1) the effect of dominant-side onset (DSO) vs non-dominant-side onset (NDSO) of Parkinson's disease (PD) on motor impairment in a large multicenter cohort…
  • 2016 International Congress

    Exploring aging-VMAT2 gene-rotenone interactions in a cell model for Parkinson’s disease

    H. Jiang, J. Li, C. Han, K. Ma, L. Liu, Y. Shen, L. Wang, S. Guo, Y. Xia, J. Huang, T. Wang (Wuhan, People's Republic of China)

    Objective: To develop a Parkinson's disease (PD) model based on aging, vesicular monoamine transporter 2 (VMAT2) gene susceptibility and chronic rotenone exposure in SK-N-SH cell,…
  • 2016 International Congress

    Saliva swallowing frequency measured using 24-hours ambulatory impedance-pH monitoring in patients with Parkinson’s disease and drooling

    J.G. Kalf, S. Scholten, W. Hopman (Nijmegen, Netherlands)

    Objective: To assess the feasibility of using 24-hours ambulatory impedance-pH monitoring (24-hAlpHM) to precisely measure saliva swallowing frequency (SSF) in patients with Parkinson's disease (PD).…
  • 2016 International Congress

    Characteristics of the interaction between different toxic aggregated species of alpha-synuclein and cell membrane

    A.T. Marvian, D. Morshedi, F. Aliakbari, H. Ghapani, M. Nasuti (Tehran, Islamic Republic of Iran)

    Objective: To determine (1) the interaction rate of each toxic aggregated species of alpha-synuclein (α-Syn) with cell membrane compare to the monomeric form, (2) the…
  • 2016 International Congress

    Differential vulnerability to α-synuclein pathology among neuronal subpopulations

    E. Luna, D.M. Riddle, V.M.Y. Lee, K.C. Luk (Philadelphia, PA, USA)

    Objective: To identify the cell death pathway(s) activated by α-synuclein (α-syn) pathology in an in vitro model of Lewy pathology and determine if neuronal subpopulations…
  • 2016 International Congress

    Circadian dysfunction in Parkinson’s disease: Effects on impaired gait initiation and locomotion

    L. Alibiglou, J. Stewart, G. Bachman, C. Cooper, L. Liu, S. Ancoli-Israel (Chicago, IL, USA)

    Objective: To investigate the impact of circadian rhythm (CR) and time of the day on the magnitude of motor impairments during gait initiation and continuation…
  • 2016 International Congress

    Colonic microbiome in Korean patients with Parkinson’s disease

    D. Lee, Y.N. Kwon, T.B. Ahn (Seoul, Korea)

    Objective: In this study we investigated the relationship between colonic microbiome and clinical features of the patients with homogeneous ethnicity. Background: Colonic microbiome is an…
  • 2016 International Congress

    Molecular landscape of Parkinson’s disease reveals a key role for lipids and lipoproteins

    C.J.H.M. Klemann, G.J.M. Martens, M. Sharma, M.B. Martens, O. Isacson, T. Gasser, J.E. Visser, G. Poelmans (Nijmegen, Netherlands)

    Objective: Integrate available genetic and expression data to generate a molecular landscape of Parkinson's disease (PD) in order to identify key disease mechanisms that may…
  • 2016 International Congress

    DJ-1 regulates intracellular signaling in a highly cell type specific manner

    F. Giesert, D.M. Vogt Weisenhorn, U. Hafen, A. Romanov, A. Kurz-Drexler, W. Wurst (Neuherberg, Germany)

    Objective: To evaluate a cell type specific action of DJ-1, a PD and cancer associated gene, in intracellular signaling pathways. Background: Understanding the pathophysiology of…
  • « Previous Page
  • 1
  • …
  • 1428
  • 1429
  • 1430
  • 1431
  • 1432
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley